FIELD: organic chemistry, biochemistry, pharmacy.
SUBSTANCE: invention relates to compounds of the general formula (I):
wherein R1 represents the following groups:
wherein * means the addition point; R4 means fluorine, chlorine, bromine atom, -CF3, -N=C, -CH3, -OCF3 or -CH2OH; R5 means chlorine, bromine atom or -OCH3; R6 means -CH3 or chlorine atom; R7 means -CH3 or chlorine atom; R8 means -CH3, fluorine, chlorine atom or -CF3; R2 represents pyridyl or group:
or ; R3 represents hydrogen or fluorine atom, and their tautomers, E-isomers or Z-isomers, racemates, enantiomers and salts also that are inhibitors of activity of tyrosine kinase KDR and FLT. Also, invention describes medicinal agents comprising the claimed compounds and designated for treatment of diseases associated with inhibition of activity of kinase KDR and FLT.
EFFECT: valuable biochemical and medicinal properties of compounds.
6 cl, 1 tbl, 30 ex
Title | Year | Author | Number |
---|---|---|---|
ANTHRANYLAMIDES AND THEIR USING AS MEDICINAL AGENTS | 2001 |
|
RU2263664C2 |
SUBSTITUTED AMIDES OF BENZOIC ACID AND PHARMACEUTICAL PREPARATION CONTAINING THEM | 2001 |
|
RU2353618C2 |
ANTHRANYLAMIDEPYRIDINE AMIDES WITH SELECTIVE EFFECT AS INHIBITORS OF VEGFR-2 AND VEGFR-3 | 2002 |
|
RU2299208C2 |
NEW ANTHRANILAMIDOPYRIDINEUREAS AS VEGF RECEPTOR KINASE INHIBITORS | 2005 |
|
RU2415850C2 |
ANTHRANILIC ACID AND THIOANTHRANILIC ACID N-ARYLAMIDES | 1999 |
|
RU2286338C2 |
ANTHRANILIC ACID AMIDES AND THEIR USING IN PHARMACEUTICALS | 2002 |
|
RU2315756C2 |
DERIVATIVES OF PIPERAZINE, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2194048C2 |
COMBINATIONS AND COMPOSITIONS EFFECTING ON FUNCTION OF VEGF/VEGF RECEPTOR AND ANGIOPOIETIN/TIE(II) RECEPTOR SYSTEMS AND USES THEREOF | 2001 |
|
RU2292221C2 |
SULFONAMIDES AND PHARMACEUTICAL PREPARATION | 1995 |
|
RU2162084C2 |
DERIVATIVES OF CHROMONE, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2156250C2 |
Authors
Dates
2005-11-20—Published
2001-05-08—Filed